Pirfenidone–flavonoid cocrystals with reduced solubility and dissolution rate-Reference-Cited by-同舟云学术

Pirfenidone–flavonoid cocrystals with reduced solubility and dissolution rate

Published:2023 Issue:36 Volume:25 Page:5133-5140
ISSN:1466-8033
Container-title:CrystEngComm
language:en
Short-container-title:CrystEngComm

Author:

Meng Lingshan¹²,Li Duanxiu²³^ORCID,Zhu Yujing²,Wang Jianming⁴,Deng Zongwu²^ORCID,Zhang Hailu¹²^ORCID

Affiliation:

1. Nano Science and Technology Institute, University of Science and Technology of China, Suzhou 215123, P. R. China

2. Laboratory of Pharmaceutical Solid-State Chemistry, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academic of Sciences, Suzhou 215123, P. R. China

3. Guangdong Institute of Semiconductor Micro-Nano Manufacturing Technology, Foshan 528200, P. R. China

4. Crystal Formulation Services, Suzhou 215127, P. R. China

Abstract

Two pirfenidone–flavonoid cocrystals with sustained release property were obtained.

Funder

National Natural Science Foundation of China

Basic and Applied Basic Research Foundation of Guangdong Province

Publisher

Royal Society of Chemistry (RSC)

Subject

Condensed Matter Physics,General Materials Science,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/CE/D3CE00402C

Reference33 articles.

1. Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs

2. Creating Cocrystals: A Review of Pharmaceutical Cocrystal Preparation Routes and Applications

3. Enhancing the stability of active pharmaceutical ingredients by the cocrystal strategy

4. Cocrystal engineering of pharmaceutical solids: therapeutic potential and challenges

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymorphs of praziquantel–succinic acid cocrystal: Crystal structure, thermodynamic relationship, and improved pharmaceutical performance;Journal of Molecular Structure;2024-07